Evaxion Biotech A/S
Evaxion Biotech A/S (EVAX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
evax · stock forecast · 4 analysts (3M) · FMP · updated Jun 9, 2026
Analyst Rating & Consensus
Based on 4 Wall Street analysts in the past 3 months
Buy
4 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$10.00
Consensus
$9.50
+154.7% upside
Low
$9.00
Median: $9.5 · Last Close: $3.73
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$9.50
154.7% upside
High Target
$10
168.1%
Low Target
$9
141.3%
Current Price
$3.73
as of today
Based on analyst price targets, the EVAX stock price prediction for the next 12 months ranges from $9 to $10. The consensus EVAX price forecast of $9.50 implies 154.7% upside from the current price of $3.73.
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $3.58 | ↓ 4.14% |
1-day model range: $3.51–$3.64. Peak: $3.64 (-4.14%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · EVAX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-04-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-09 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-09 | Lake Street | Maintains | Buy→Buy |
| 2025-10-20 | Lake Street | Maintains | Buy→Buy |
| 2025-10-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-04-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-04 | Lake Street | Maintains | Buy→Buy |
| 2025-02-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Evaxion Biotech A/S (EVAX) stock. Of the recent 23 rating actions, 1 were upgrades and 1 were downgrades. 4 analysts currently cover EVAX.
Analyst Recommendation Trends
EVAX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 3 to 1 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$5M
↓ 78.1% YoY
Revenue Next Year
$23M
↑ 329.1% YoY
EPS This Year
$-0.03
EPS Next Year
$0.04
↓ 260.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast EVAX EPS of $-0.03 for the current fiscal year, based on estimates from 1 analysts. The EVAX revenue forecast is $5M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The EVAX stock forecast is supported by two independent data sources: analyst consensus ratings from 4 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus EVAX price target is $9.50 (+154.7% upside), with an analyst consensus of Buy.
The EVAX short-term stock prediction for tomorrow is $3.58 (-4.14%).
Evaxion Biotech A/S trades on NASDAQ under the ticker EVAX. The EVAX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
EVAX forecast · 8 questionsAccording to 4 Wall Street analysts, the average 12-month EVAX price target is $9.50, with a high forecast of $10.00 and a low of $9.00. The median price target is shown in the chart above when available. This implies +154.7% potential upside from the current price of $3.73.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.